GERN Q4 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+1.0% YoY

Gross Profit

$47M97.3% margin

Operating Income

-$11M-22.5% margin

Net Income

-$31M-64.9% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$571M

Total Liabilities

$347M

Stockholders' Equity

$224M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$48M	+1.0%
Gross Profit	$47M	$47M	-0.1%
Operating Income	-$11M	-$20M	+46.2%
Net Income	-$31M	-$25M	-22.8%

Revenue Segments

Revenues Before Adjustments

$60M55%

Product

$48M45%

Government Rebates

$65,0000%